Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 8
Submit an article Journal homepage
771
Views
20
CrossRef citations to date
0
Altmetric
Reviews

Current trends in molecular diagnostics of chronic myeloid leukemia

Raquel VinhasDepartamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, UCIBIO, Universidade Nova de Lisboa, Caparica, Portugal
,
Milton CordeiroDepartamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, UCIBIO, Universidade Nova de Lisboa, Caparica, Portugal
,
Pedro PedrosaDepartamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, UCIBIO, Universidade Nova de Lisboa, Caparica, Portugal
,
Alexandra R. FernandesDepartamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, UCIBIO, Universidade Nova de Lisboa, Caparica, PortugalCorrespondence[email protected]
&
Pedro V. BaptistaDepartamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, UCIBIO, Universidade Nova de Lisboa, Caparica, Portugal
Pages 1791-1804 | Received 26 Jul 2016, Accepted 19 Nov 2016, Published online: 06 Dec 2016

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Shan Zhang, Hurong Lai, Huijun Chen, Jingyu Wang, Huaijun Tu & Jian Li. (2023) Comparative efficacy and safety of different doses of ponatinib versus other tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia: a systematic review and network meta-analysis. Expert Opinion on Drug Safety 0:0, pages 1-9.
Read now
Raquel Vinhas, Alexandra Lourenço, Susana Santos, Marcos Lemos, Patrícia Ribeiro, Aida Botelho de Sousa, Pedro Viana Baptista & Alexandra Ramos Fernandes. (2018) A novel BCR-ABL1 mutation in a patient with Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia. OncoTargets and Therapy 11, pages 8589-8598.
Read now

Articles from other publishers (18)

Bilal Abdulmawjood, Catarina Roma‐Rodrigues, Pedro V. Baptista & Alexandra R. Fernandes. (2023) Tackling Imatinib Resistance via Au‐nanoconjugates using A Cml Resistant Cell Line. Particle & Particle Systems Characterization.
Crossref
S. Malathi, S. Narayana Kalkura & S. Balasubramanian. 2023. Applications of Multifunctional Nanomaterials. Applications of Multifunctional Nanomaterials 651 691 .
Md Salman Shakil, Mahruba Sultana Niloy, Kazi Mustafa Mahmud, Mohammad Amjad Kamal & Md Asiful Islam. (2022) Theranostic Potentials of Gold Nanomaterials in Hematological Malignancies. Cancers 14:13, pages 3047.
Crossref
Negin Fasih Ramandi, Ilnaz Soleimani Mashhadi, Amirreza Sharif, Negar Saeedi, Mohammad Ali Ashabi, Mohammad Faranoush, Alireza Ghassempour & Hassan Y. Aboul-Enein. (2022) Study of Glutathione S-transferase-P1 in cancer blood plasma after extraction by affinity magnetic nanoparticles and monitoring by MALDI-TOF, IM-Q-TOF and LC-ESI-Q-TOF MS. Journal of Chromatography B 1190, pages 123091.
Crossref
Fangyi Yao, Cui Zhao, Fangmin Zhong, Tingyu Qin, Shuqi Li, Jing Liu, Bo Huang & Xiaozhong Wang. (2022) Bioinformatics analysis and identification of hub genes and immune-related molecular mechanisms in chronic myeloid leukemia. PeerJ 10, pages e12616.
Crossref
Stefan G. C. Mestrum, Anton H. N. Hopman, Frans C. S. Ramaekers & Math P. G. Leers. (2021) The potential of proliferative and apoptotic parameters in clinical flow cytometry of myeloid malignancies. Blood Advances 5:7, pages 2040-2052.
Crossref
Zhuoya Wan, Runzi Sun, Pearl Moharil, Jing Chen, Yuzhe Liu, Xu Song & Qiang Ao. (2021) Research advances in nanomedicine, immunotherapy, and combination therapy for leukemia. Journal of Leukocyte Biology 109:2, pages 425-436.
Crossref
Julie Li & Gang Zheng. 2021. Practical Oncologic Molecular Pathology. Practical Oncologic Molecular Pathology 305 323 .
Tal Gilboa, Padric M. Garden & Limor Cohen. (2020) Single-molecule analysis of nucleic acid biomarkers – A review. Analytica Chimica Acta 1115, pages 61-85.
Crossref
Pedro Viana Baptista. 2020. Nanoparticles in Biology and Medicine. Nanoparticles in Biology and Medicine 251 268 .
Peng Zhang, Wen‐Wei Yu, Jing Peng, Liang‐Fei Xu, Chang‐Cheng Zhao, Wen‐Jiao Chang & Xiao‐Ling Ma. (2019) LukS‐PV induces apoptosis in acute myeloid leukemia cells mediated by C5a receptor. Cancer Medicine 8:5, pages 2474-2483.
Crossref
Yu Fu, Rui Zhang, Qisheng Wu, Jiawei Zhang, Lihua Bao & Jinming Li. (2018) External quality assessment of p210 BCR‐ABL1 transcript quantification by RT‐qPCR: Findings and recommendations . International Journal of Laboratory Hematology 41:1, pages 46-54.
Crossref
Ana Sofia Matias, Raquel Vinhas, Rita Mendes, Alexandra R. Fernandes & Pedro Viana Baptista. (2019) Nanoparticles as Emerging Diagnostic Tools in Liquid Tumours. EMJ Innovations, pages 80-87.
Crossref
Elizabeth O'Day, Leticia Hosta‐Rigau, Diego A. Oyarzún, Hideyuki Okano, Víctor de Lorenzo, Conrad von Kameke, Habiba Alsafar, Cong Cao, Guo‐Qiang Chen, Weizhi Ji, Richard J. Roberts, Mostafa Ronaghi, Karen Yeung, Feng Zhang & Sang Yup Lee. (2018) Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health. Biotechnology Journal 14:1.
Crossref
Mariana M. Fachi, Fernanda S. Tonin, Leticia P. Leonart, Karina S. Aguiar, Luana Lenzi, Bonald C. Figueiredo, Fernando Fernandez-Llimos & Roberto Pontarolo. (2018) Comparative efficacy and safety of tyrosine kinase inhibitors for chronic myeloid leukaemia: A systematic review and network meta-analysis. European Journal of Cancer 104, pages 9-20.
Crossref
Karen Yasmim Pereira dos Santos Avelino, Isaac Aarón Morales Frías, Norma Lucena-Silva, César Augusto Souza de Andrade & Maria Danielly Lima de Oliveira. (2018) Impedimetric gene assay for BCR/ABL transcripts in plasmids of patients with chronic myeloid leukemia. Microchimica Acta 185:9.
Crossref
Raquel Vinhas, Rita Mendes, Alexandra R. Fernandes & Pedro V. Baptista. (2017) Nanoparticles—Emerging Potential for Managing Leukemia and Lymphoma. Frontiers in Bioengineering and Biotechnology 5.
Crossref
Raquel Vinhas, Alexandra R. Fernandes & Pedro V. Baptista. (2017) Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia. Molecular Therapy - Nucleic Acids 7, pages 408-416.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.